Maharashtra's FDA to issue UID-linked e-signed licenses

Image
Press Trust of India Mumbai
Last Updated : Jan 28 2016 | 7:48 PM IST

Don't want to miss the best from Business Standard?

In a first-of-its-kind initiative in the country, Maharashtra's Food and Drug Administration (FDA) has started issuing all sale licenses for medicines through online application software with e-signature having organic authentication on Aadhaar (UIDAI) server.
"The step is part of the Maharashtra government's e-Governance policy and the central government's 'Digital India' programme and 'Ease of doing business' initiative," Maharashtra FDA Commissioner Harshadeep Kamble said.
FDA Maharashtra is the first office in India to provide such a service, he said. These licenses have unique TPAV number which can be verified at www.Xlnindia.Gov.In.
The process for obtaining licenses for sale of medicines is paperless, right from submitting an application to grant of license and is time-bound, transparent and user-friendly, the senior IAS officer said.
The applicant can now make an application online, upload documents digitally, pay fee through payment gateway of the Maharashtra government gras.Mahakosh.Gov.In.
This application software is linked to virtual treasury office of government of Maharashtra since June 2015, and the fee paid is verified online, he said.
The applications will be processed online and the applicant can see the status of the application online. And after grant of license, the applicant receives the information by SMS besides a downloadable copy.
The applicant need not visit the office of FDA at all, as the whole process is now paperless, Kamble said.
"The software and the technology applied is seamless and transparent to reduce the discretionary powers with the Licensing Authority.
"Applications to be disposed within specified period are automatically highlighted. The Drug Inspector, after inspection of site, has to submit his report online," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 28 2016 | 7:48 PM IST

Next Story